Kelsey Carpenter, Ph.D. completed her doctorate in integrated biomedical sciences at Rush University in Chicago, Illinois, and is currently a postdoctoral researcher in the Grainger Lab at Van Andel Institute's Department of Cell Biology. It's here that Dr. Carpenter studies the origins of blood cancers by focusing on how blood cells develop.
The more we understand this process, Dr. Carpenter explains, the more opportunities we have to fix problems and, hopefully, treat or prevent cancer.
What makes you passionate about your work?
My passion for my work is fueled by the powerful stories of people who battle blood cancer. Each year, nearly 200,000 people in the U.S. are diagnosed with some form of blood cancer, and their strength and resilience inspire me every day. I'm driven by the hope that my research can lead to meaningful breakthroughs that offer a path to new treatment options and a better future for those affected. Supporting these patients through science is my motivation and mission.
How have the funds contributed by the American Cancer Society made a difference in your research?
Receiving an American Cancer Society Postdoctoral Fellowship has been instrumental in turning my scientific ideas into reality. This generous award enables me to focus entirely on conducting research on blood cancer. It allows me the freedom to pursue innovative experiments and generate meaningful data.
In addition, the fellowship supports travel to national and international scientific conferences, where I engage with leading researchers, share my work and stay informed about the latest breakthroughs. These experiences foster valuable collaborations, spark new ideas and inspire continued progress. I'm incredibly grateful for the support, which not only facilitates my current work but also lays the foundation for a lifelong career dedicated to cancer research.
What are your hopes and goals for the future of your research?
My hope is to contribute to new therapies for blood cancer. This disease is incredibly complex, with many factors influencing how it develops, progresses and responds to treatment. Advancing our understanding requires collaboration across disciplines, institutions and perspectives. My long-term goal is to make lasting contributions that move the field forward. I believe that by working together—researchers, physicians, patients and advocates—we can improve outcomes for those affected by blood cancers.
Learn more:
- American Cancer Society | cancer.org
- Van Andel Institute | vai.org
Edited by Sarah Suydam, Managing Editor for West Michigan Woman.
This article originally appeared in the Oct/Nov '25 issue of West Michigan Woman.
Photo courtesy of the Van Andel Institute.
